Literature DB >> 17626973

Successful treatment with bosentan for severe digital ischaemia in limited cutaneous systemic sclerosis.

Emma P K Yu, Andrew J K Ostor, Frances C Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17626973      PMCID： PMC1954684          DOI： 10.1136/ard.2006.057604

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

Review 1.  Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension.

Authors:  T K Jeffery; J C Wanstall
Journal:  Pharmacol Ther       Date:  2001-10       Impact factor: 12.310

Review 2.  Treatment of pulmonary arterial hypertension.

Authors:  Marc Humbert; Olivier Sitbon; Gérald Simonneau
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

Review 3.  Pathogenesis of Raynaud's phenomenon.

Authors:  A L Herrick
Journal:  Rheumatology (Oxford)       Date:  2005-03-01       Impact factor: 7.580

4.  Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Authors:  J H Korn; M Mayes; M Matucci Cerinic; M Rainisio; J Pope; E Hachulla; E Rich; P Carpentier; J Molitor; J R Seibold; V Hsu; L Guillevin; S Chatterjee; H H Peter; J Coppock; A Herrick; P A Merkel; R Simms; C P Denton; D Furst; N Nguyen; M Gaitonde; Carol Black
Journal:  Arthritis Rheum       Date:  2004-12

5.  Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

Authors:  M H Williams; C Das; C E Handler; M R Akram; J Davar; C P Denton; C J Smith; C M Black; J G Coghlan
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

6.  Survival with first-line bosentan in patients with primary pulmonary hypertension.

Authors:  V V McLaughlin; O Sitbon; D B Badesch; R J Barst; C Black; N Galiè; M Rainisio; G Simonneau; L J Rubin
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

Review 7.  Raynaud phenomenon and the vascular disease in scleroderma.

Authors:  M Bashar Kahaleh
Journal:  Curr Opin Rheumatol       Date:  2004-11       Impact factor: 5.006
  7 in total
  2 in total

1.  [Critical limb ischemia in systemic sclerosis].

Authors:  M O Becker; G Riemekasten
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

2.  Treatment resistant severe digital ischemia associated with antiphospholipid syndrome in a male patient with systemic sclerosis.

Authors:  Orhan Küçükşahin; Aşkın Ateş; Alexis K Okoh; Emre Kulahcioglu; Murat Turgay; Gülay Kınıklı
Journal:  Case Rep Rheumatol       Date:  2014-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.